
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | 2026-05-20 | Sebelius Kathleen | Director | Purchase | 56.8K | $0.88 | $50K | 148.0K | View ↗ | |
| 2026-05-18 | 2026-05-20 | Constantino Michael T. | Director | Purchase | 11.0K | $0.89 | $10K | 44.0K | View ↗ | |
| 2026-05-18 | 2026-05-20 | Sander Dale A. | CFO and Chief Corp. Dev. Off | Sale | 45.9K | $0.90 | $41K | 267.2K | View ↗ |
No annual data found.
Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access
Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs
Why Humacyte, Inc. (HUMA) Price Target Was Raised Despite Early-Stage Commercialization
Humacyte Inc (HUMA) Q1 2026 Earnings Call Highlights: Sales Surge and Strategic Expansions Amid ...